Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population

BMC Medical Genetics

Dongsheng Hu²  Qian Wang¹  Yan Wang¹  Linlin Li¹  Lei Yin³  Jingzhi Zhao³  Tianping Feng³  Fulan Hu⁴  Jinjin Wang¹ 

[1] Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450000, People’s Republic of China;Shenzhen University School of Medicine, Shenzhen, 518000, People’s Republic of China;Military Hospital of Henan Province, Zhengzhou, 450000, People’s Republic of China;Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, 150086, People’s Republic of China

关键词: Meta-analysis;    SNPs;    TCF7L2;    T2DM;    Type 2 diabetes;   

Others  :  1177747
DOI  :  10.1186/1471-2350-14-8

 received in 2012-04-09, accepted in 2013-01-07,  发布年份 2013

【 摘 要 】

Background

Associations between transcription factor 7-like 2 (TCF7L2) polymorphisms and type 2 diabetes mellitus (T2DM) have been evaluated extensively in multiple ethnic groups. TCF7L2 has emerged as the strongest T2DM susceptibility gene in Europeans, but the findings have been inconsistent in the Chinese population. The purpose of this meta-analysis was to evaluate the associations between TCF7L2 single nucleotide polymorphisms (SNPs) and T2DM risk in the Chinese population.

Methods

We performed searches in the PubMed, EMBASE, Cochrane, and Chinese databases (CNKI, CQVIP and Wanfang databases) for literature published from January 2007 to February 2012. We reviewed all relevant articles on TCF7L2 polymorphisms and susceptibility to T2DM in the Chinese population written in English and Chinese. Two reviewers extracted data independently using a standardized protocol, and any discrepancies were adjudicated by a third reviewer. Fixed-effects and random-effects meta-analyses were performed to pool the odds ratios (ORs). Publication bias and heterogeneity were examined.

Results

A total of 21 articles were confirmed to be eligible for and included in this meta-analysis: 7 (with 3942 cases and 3502 controls) concerning rs11196218 (IVS−/+4G>A), 8 (with 3377 cases and 2975 controls) concerning rs290487 (IVS3−/+C>T), and 14 (with 7902 cases and 7436 controls) concerning rs7903146 (IVS3−/+C>T). Overall, the results showed a significant association between rs7903146 and T2DM risk. The pooled ORs were 1.54 for the comparison of T and C alleles (95% CI [confidence interval]: 1.37–1.74, p = 1.47 × 10^-12, I² = 25.20%) and 1.56 for TC heterozygotes and CC homozygotes (95% CI : 1.38–1.76, p = 8.25 × 10^-9, I² = 21.00%). The rs11196218(IVS4G>A) and rs290487 (IVS3C>T) SNPs were not associated with T2DM risk.

Conclusions

The rs7903146 SNP of the TCF7L2 gene is associated with increased susceptibility to T2DM in the Chinese population as a whole as well as northern Chinese and southern Chinese as subgroups.

【 授权许可】

   
2013 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365(9467):1333-1346.
• [2]Roglic G, King H: Diabetes mellitus in Asia. Hong Kong Med J 2000, 6(1):10-11.
• [3]King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21(9):1414-1431.
• [4]American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 2000, 23(3):381-389.
• [5]Flores-Martinez SE, Islas-Andrade S, Machorro-Lazo MV, Revilla MC, Juarez RE, Mujica-Lopez KI, Moran-Moguel MC, Lopez-Cardona MG, Sanchez-Corona J: DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group. Ann Genet 2004, 47(4):339-348.
• [6]Radha V, Mohan V: Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res 2007, 125(3):259-274.
• [7]Elbein SC: The genetics of human noninsulin-dependent (type 2) diabetes mellitus. J Nutr 1997, 127(9):1891S-1896S.
• [8]Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87(4):1409-1439.
• [9]Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005, 280(2):1457-1464.
• [10]Ren Q, Han XY, Wang F, Zhang XY, Han LC, Luo YY, Zhou XH, Ji LN: Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population. Diabetologia 2008, 51(7):1146-1152.
• [11]Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, Chiu KC, Chuang LM: Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes 2007, 56(10):2631-2637.
• [12]Ng MC, Tam CH, Lam VK, So WY, Ma RC, Chan JC: Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. J Clin Endocrinol Metab 2007, 92(9):3733-3737.
• [13]Ng MC, Park KS, Oh B, Tam CH, Cho YM, Shin HD, Lam VK, Ma RC, So WY, Cho YS, et al.: Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 2008, 57(8):2226-2233.
• [14]Zheng X, Ren W, Zhang S, Liu J, Li S, Li J, Yang P, He J, Su S, Li P: Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Mol Biol Rep 2012, 39(1):17-23.
• [15]Yu M, Xu XJ, Yin JY, Wu J, Chen X, Gong ZC, Ren HY, Huang Q, Sheng FF, Zhou HH, et al.: KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes. Clin Pharmacol Ther 2010, 87(3):330-335.
• [16]Lou QL: The association study between SNPs in TCF7L2 and the susceptibility of T2D in Chinese Han population. Chin J Diabetes 2007, 17(12):895-898.
• [17]Zeng QC: Factor 7-like 2 (TCF7L2) Gene in Type2 Diabetes Mellitus of Chinese in Chengdu Area. In Master's thesis. University of Sichuan, Clinical Medicine Department; 2007.
• [18]Chen GY: Relationship between TCF7L2 polymorphism with T2D and related factors. Journal of Xianning University (Medical Sciences) 2011, 25(2):103-106.
• [19]Zou YL: Relationship between rs290487-T/C polymorphism of TCF7L2 gene and T2D in Kunming Han population. China Modern Doctor 2009, 47(29):11-12.
• [20]Wang ZH: Association of polymorphism in TCF7L2 and SLC30A8 with T2D in Chinese Han population. In Phd thesis. Chongqing University, Clinical Medicine Department; 2008.
• [21]Zhang L: Replication study for the association of TCF7L2 rs12255372 and rs7903146 with susceptibility to T2D in a Chinese Han population. In Master's thesis. University of South China, Clinical Medicine Department; 2010.
• [22]Ma C: Relationship of rs13266634 and rs11196218 polymorphism in SLC30A8 (solute carrier family 30, member 8) and TCF7L2 (transcription factor 7 like 2) gens with T2D in Southern Chinese Han population. In Master's thesis. Jiangsu University, Clinical Medicine Department; 2006.
• [23]Zhang Y: Study on the relationship between the rs290487 polymorphism of TCF7L2 gene and T2D mellitus. In Mater's thesis. Shandong University, Clinical Medicine Department; 2009.
• [24]Zhang Y: Association of polymorphism in TCF7L2 with T2D in Chinese Han population. In Master's thesis. Zhongnan University, Clinical Medicine Department; 2008.
• [25]Xin T: The study of single nucleotide polymorphism of susceptibility genes of type two diabetes in Chinese Han population. In Master's thesis. Chongqing Medical University, Clinical Laboratory Department; 2009.
• [26]Zhu H: Common risks of the TCF7L2 gene with T2D and impaired glucose regulation in a Chinese Han population. In Master's thesis. Anhui Medical University, Clinical Medicine Department; 2011.
• [27]Qiao H, Zhang X, Zhao X, Zhao Y, Xu L, Sun H, Fu S: Genetic variants of TCF7L2 are associated with type 2 diabetes in a northeastern Chinese population. Gene 2012, 495(2):115-119.
• [28]Zhao T: The association of transcription factor 7 like 2 polymorphisms with the early phase function of β-cell in T2D mellitus. Med J Qilu 2011, 26(5):417-20.
• [29]Wen J, Ronn T, Olsson A, Yang Z, Lu B, Du Y, Groop L, Ling C, Hu R: Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One 2010, 5(2):e9153.
• [30]Wang Y, Zhu H, Jin X, Lv Y, Cui Z, Jin Y, Zhang Z, Yang K: The association study between T2D and rs7903146 polymorphisms in TCF7L2 in Korean and Han Chinese population living in Yanbian [abstract]. China Genetics Conference Abstracts 2011, 8:s212.
• [31]Luo Y, Wang H, Han X, Ren Q, Wang F, Zhang X, Sun X, Zhou X, Ji L: Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population. Diabetes Res Clin Pract 2009, 85(2):139-146.
• [32]Tong Y, Lin Y, Zhang Y, Yang J, Zhang Y, Liu H, Zhang B: Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009, 10:15.
• [33]Cauchi S, El AY, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, et al.: TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl) 2007, 85(7):777-782.
• [34]Takeuchi M, Okamoto K, Takagi T, Ishii H: Ethnic difference in patients with type 2 diabetes mellitus in inter-East Asian populations: a systematic review and meta-analysis focusing on gene polymorphism. J Diabetes 2009, 1(4):255-262.
• [35]Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X, Takeuchi F, Wu Y, Go MJ, Yamauchi T, et al.: Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 2012, 44(1):67-72.
• [36]Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
• [37]Ling W, Farrell M, Ali R: Cochrane systematic reviews: time for an introduction and appraisal. Drug Alcohol Depend 2004, 73(3):217-218.
• [38]Mantel N, HAENSZEL W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
• [39]Midgette AS, Wong JB, Beshansky JR, Porath A, Fleming C, Pauker SG: Cost-effectiveness of streptokinase for acute myocardial infarction: a combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med Decis Making 1994, 14(2):108-117.
• [40]Noble WS: How does multiple testing correction work? Nat Biotechnol 2009, 27(12):1135-1137.
• [41]Light RJ: Summing up: the science of reviewing research. Cambridy, MA: Harvard University Press; 1984.
• [42]Egger M, Davey SG, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
• [43]Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I, et al.: Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007, 39(2):218-225.
• [44]Nakaoka H, Inoue I: Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse. J Hum Genet 2009, 54(11):615-623.